Lincoln Pharmaceuticals informs about revised disclosures

04 May 2023 Evaluate
Lincoln Pharmaceuticals has informed that the exchange has received the revised disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Mahendra Gulabdas Patel & PACs.

The above information is a part of company’s filings submitted to BSE.

Lincoln Pharma Share Price

457.15 4.30 (0.95%)
22-Jan-2026 14:37 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1624.15
Dr. Reddys Lab 1218.30
Cipla 1368.90
Zydus Lifesciences 885.25
Lupin 2163.90
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×